the capex will increase further. the stock is way overbought...

First 334 Last

Share
Profile

Follow
cobrakai1984

6,700 Posts.

584

26/10/22

11:45

Post #: 64403718
Share

Originally posted by fup: ↑

looking across at all the capex increases in the mining sector in australia (HIO basically abandoned their project, TNG announced they don't know how much extra their mine/plant is going to cost) and labour shortages (SBM shocker recently) the optimisation study costs look really undercooked now. as a reminder the dubbo optimisation study headline amounts:
Capital cost estimate of AUD 1,678 million consisting of direct capital of AUD 1,307 million, indirect capital of AUD 208 million, and a contingency of AUD 163 millionit's been almost one year since the study was released and we have seen pretty significant labour and materials supply cost increases without any similar increases in RE pricing on the revenue side. we are really in need of some hefty government intervention to get this ball rolling. the company needs to be really marketing the 'strategic' nature of the project to draw some attention away from how bad the financials are.

Expand

the capex will increase further. the stock is way overbought now. project wont receive finance imo- circa 2bil capex, unless its an andrew forrest type guy on board, which there isnt

ASM Price at posting: $2.36 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

First 334 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 53.0¢		Change 0.010(1.92%)		Mkt cap ! $96.11M

Open	High	Low	Value	Volume
52.5¢	54.0¢	52.5¢	$59.18K	110.9K

Buyers (Bids)

No.	Vol.	Price($)
4	4277	53.0¢

Sellers (Offers)

Price($)	Vol.	No.
53.5¢	19854	3

View Market Depth

No.	Vol.	Price($)
4	4623	0.530
1	4194	0.525
5	67583	0.520
4	20334	0.515
4	15534	0.510

Price($)	Vol.	No.
0.535	19898	3
0.540	26859	5
0.545	3896	3
0.550	14140	3
0.560	37340	2

Last trade - 12.29pm 27/06/2025 (20 minute delay)

ASM (ASX) Chart

the capex will increase further. the stock is way overbought...

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

the capex will increase further. the stock is way overbought...

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News